The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert on the recall of two lots of Norvasc 5mg tablets. The recall was ordered by the Taiwan Food and Drug Administration (FDA) after the discovery of iron wires in samples taken from a shipment of six million tablets produced by U.S.-based drug developer Viatris Inc. Long-term local Norvasc users have also reported finding iron wires inside the tablets.
Norvasc 5mg tablets contain amlodipine besylate, which is used to treat high blood pressure or angina.
The affected batches are FR3135 and FT2343 – see the image below.
NAFDAC advises importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to avoid importing, distributing, selling, or using these affected batches.
Members of the public in possession of these products are advised to discontinue sale or use and submit stock to the nearest NAFDAC office. If you have used these products or suffered any adverse reaction/event after use, seek immediate medical advice from a qualified healthcare professional. Healthcare professionals and consumers are advised to report any suspicion of substandard and falsified medicines to NAFDAC.
Source:
National Agency for Food and Drugs Administration and Control. (2023, March 28). Public Alert No. 010/2023 – Alert on Recall of Two lots of Norvasc 5mg Tablets. NAFDAC. Available from: https://www.nafdac.gov.ng/public-alert-no-010-2023-alert-on-recall-of-two-lots-of-norvasc-5mg-tablets/